(Q34630644)

English

Treatment of osteopenia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2 references

13 March 2019

24 March 2019

Treatment of osteopenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

metabolic bone disease

2 references

13 March 2019

24 March 2019

author name string

Erik Fink Eriksen

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 September 2012

3 references

Europe PubMed Central

PubMed publication ID

3 August 2017

13 March 2019

24 March 2019

Reviews in Endocrine and Metabolic Disorders

3 references

Europe PubMed Central

PubMed publication ID

3 August 2017

13 March 2019

24 March 2019

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

209-223

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

https://scigraph.springernature.com/pub.10.1007/s11154-011-9187-z

0 references

Lasofoxifene in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Interventions for preventing falls in older people living in the community

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Spine radiographs to improve the identification of women at high risk for fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Cancer treatment-induced bone loss in breast and prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Zoledronic acid and clinical fractures and mortality after hip fracture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Fracture prevention with vitamin D supplementation: considering the inconsistent results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Clinical relevance of vertebral fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Testosterone replacement therapy and prostate risks: where's the beef?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

The Vitamin D requirement in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Exercise as an anabolic stimulus for bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Bone mineral density thresholds for pharmacological intervention to prevent fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Effect of Vitamin D on falls: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Patients with eating disorders. A high-risk group for fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Effect on hip fractures of increased use of hip protectors in nursing homes: cluster randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Role of the vitamin D-endocrine system in the pathophysiology of postmenopausal osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Primary hyperparathyroidism: lessons from bone histomorphometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Clinical review 144: Estrogen and the male skeleton

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Hip protectors in aged-care facilities: a randomized trial of use by individual higher-risk residents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Prevalence of low serum estradiol levels in male osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Molecular mechanisms of action of bisphosphonates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Esophagitis associated with the use of alendronate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Bone mass and exercise

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Reduced bone mineral in patients with eating disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: a randomized study comparing intermittent treatment and an ADFR regime

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Avian osteoclasts as estrogen target cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

7 July 2018

Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of-1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Effects of different treatments for osteoporosis on prevention of fractures: toward and individualized and economic approach

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Vertebral Fracture Assessment: the 2007 ISCD Official Positions.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Prevention of hip fracture by external hip protectors: an intervention in 17 nursing homes in two municipalities in Norway.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

The effect of type of hip protector and resident characteristics on adherence to use of hip protectors in nursing and residential homes--an exploratory study.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Rapidly shifting concepts regarding androgens and prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Osteonecrosis of the jaw--a potential adverse effect of bisphosphonate treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

26 October 2018

Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

26 October 2018

The effects of alendronate on bone turnover and bone quality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

26 October 2018

Prevention of hip fractures in older women: a population-based perspective.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

26 October 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Determinants of Bone Mineral Density in Older Men

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Bone and Fall-Related Fracture Risks in Women and Men with a Recent Clinical Fracture

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Clinical subsequent fractures cluster in time after first fractures

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1 reference

https://api.crossref.org/works/10.1007%2FS11154-011-9187-Z

21 January 2018

Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411311

9 December 2018

Mortality after osteoporotic fractures

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FRAX assessment of osteoporotic fracture probability in Switzerland

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Number of patients to be treated and number of prevented fractures: clinical efficiency of osteoporosis treatment with diphosphonate alendronate]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe vitamin D deficiency in Swiss hip fracture patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of estrogen receptors in normal human osteoblast-like cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21710179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11154-011-9187-Z

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34630644&oldid=1579779983"